AlphAIalphai — Financial news for AI agents
SEC EDGARAUG 251 min read$CON

ORTENZIO ROBERT A sold (to issuer) $8.0M of CON (indirect holdings)

ORTENZIO ROBERT A sold (to issuer) 230,000 indirectly-held shares of Concentra Group Holdings Parent, Inc. (CON) at an average of $34.78 ($34.65–$35.65, $8.00M total) across 4 trades on 2026-08-21.

Original reporting
SEC EDGAR · ORTENZIO ROBERT A
Published Aug 25, 2026, 9:03 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 25, 2026, 9:10 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$CON
Neutral
medium confidence
Mentioned
$CON
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CONNeutralLow
01

Why it matters

The disclosure provides fresh data on insider holdings, useful for short‑term sentiment assessment.

02

Market read

Insider sale of $8M is a modest signal; traders may monitor for further insider activity.

03

What to watch

Potential tax planning or liquidity needs for the director.

Relevance 6/10Novelty 7/10Timing: filed Aug 25, 2026 (post‑transaction)

Background

Form 4 filings disclose insider transactions; this is the first public report of Ortenzio's sale.

Company-level read

Ticker impact

$CONNeutralMedium confidence
Context

Director Robert Ortenzio sold 230,000 shares for $8.0M on Aug 21, reducing his stake to 206,286 shares.

Expected impact

Potential slight downward pressure on CON stock in the short term.

Evidence & confidence

A $8M sale by a director is notable but not large enough to drive a significant price move.

Market effects

Sector

Minimal impact on the healthcare services sector; insider activity is routine.

Regional

No broader regional effect.

Global

Limited to investors tracking CON.

Counterpoint

What could challenge this read

The sale could be unrelated to company fundamentals; price may remain stable.

Key entities

  • Company
    Concentra Group Holdings Parent, Inc.

    Healthcare services provider listed under ticker CON.

  • Individual
    Robert Ortenzio

    Director of CON who sold shares.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

CON insider trading history →

Related articles

AUG 14
$CONHighAI 9/10

Concentra (CON) Q2 2026 Earnings Call Transcript

Concentra Group Holdings Parent (CON) reported Q2 2026 revenue of $606 million (+10% YoY) and adjusted EBITDA of $140.9 million (+22.5%), with adjusted EPS of $0.52. Management raised full-year guidance: revenue to $2.325B-$2.375B and adjusted EBITDA to $485M-$495M. Net leverage fell to 2.99x. A CEO transition to Matt DiCanio takes effect Nov. 1, 2026.

fool.com6 min
AUG 6
$CONHigh

Concentra Group Holdings Parent, Inc. (CON): Results of Operations and Financial Condition

Concentra Group Holdings Parent, Inc. (CON) filed an SEC Form 8-K — Results of Operations and Financial Condition. NEWS RELEASE FOR IMMEDIATE RELEASE Concentra Group Holdings Parent, Inc. Announces Results For Its Second Quarter Ended June 30, 2026 and Raises FY 2026 Guidance Matt DiCanio to become president and CEO and Keith Newton to transition to executive chairman, effective Nov. 1, 2026

SEC EDGAR 8-K6 min